folder

Rapid differentiation of MOGAD and MS after a single optic neuritis

Authors

  • T. Pakeerathan
  • J. Havla
  • C. Schwake
  • A. Salmen
  • M. Ringelstein
  • O. Aktas
  • M. Weise
  • J.A. Gernert
  • B. Kornek
  • G. Bsteh
  • A.K. Pröbstel
  • A. Papadopoulou
  • L. Kulsvehagen
  • A.B. Ayroza Galvão Ribeiro Gomes
  • N. Cerdá-Fuertes
  • F.C. Oertel
  • A.S. Duchow
  • F. Paul
  • J.P. Stellmann
  • N. Stolowy
  • K. Hellwig
  • C. Schneider-Gold
  • T. Kümpfel
  • R. Gold
  • P. Albrecht
  • I. Ayzenberg

Journal

  • Journal of Neurology

Citation

  • J Neurol 271 (11): 7222-7231

Abstract

  • BACKGROUND: Optic neuritis (ON) is a common manifestation of multiple sclerosis (MS) and myelin-oligodendrocyte-glycoprotein IgG-associated disease (MOGAD). This study evaluated the applicability of optical coherence tomography (OCT) for differentiating between both diseases in two independent cohorts. METHODS: One hundred sixty two patients from seven sites underwent standard OCT and high-contrast visual acuity (HCVA) testing at least 6 months after first ON. Of these, 100 patients (32 MOGAD, 68 MS) comprised the primary investigational cohort, while 62 patients (31 MOGAD, 31 MS) formed a validation cohort. A composite score distinguishing between MOGAD and MS was developed using multivariate logistic regression. RESULTS: Bilateral simultaneous ON occurred more frequently in MOGAD compared to MS (46.9 vs. 11.8%, p < 0.001). OCT revealed more peripapillary retinal nerve fiber layer (pRNFL) atrophy in all segments in MOGAD compared to predominantly temporal pRNFL atrophy in MS (p < 0.001). HCVA was better preserved in MS (p = 0.007). pRNFL thickness in all except for temporal segments was suitable for differentiating MOGAD and MS. Simultaneous bilateral ON and critical atrophy in nasal (< 58.5 µm) and temporal superior (< 105.5 µm) segments were included into the composite score as three independent predictors for MOGAD. The composite score distinguished MOGAD from MS with 75% sensitivity and 90% specificity in the investigational cohort, and 68% sensitivity and 87% specificity in the validation cohort. CONCLUSION: Following a single ON-episode, MOGAD exhibits more pronounced global pRNFL atrophy and lower visual acuity after ON compared to MS. The introduced OCT-based composite score enabled differentiation between the two entities across both cohorts.


DOI

doi:10.1007/s00415-024-12666-w